Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Tobacco Use Disorder
Interventions
DRUG

ModafinilNicotine Replacement Therapy

A dose escalation design includes eight dose conditions across a 12-day study (nicotine low-high, modafinil low-high and 4 combinations). After day 1 placebo dose, placebo sessions occur in random order during low dose, high dose, and dose-combination testing. Modafinil and nicotine are tested alone with subjects exposed to low active doses prior to higher doses. Dose interactions will be determined with low doses tested in combination followed by low-high dose combinations then high-high dose combination. Doses are administered under double-blind, double dummy procedures. A nicotine patch (0, 7 or 14 mg doses) is applied at 7 am. Modafinil doses are prepared in size 00 opaque capsules. The modafinil dose (0, 100, 200 mg) is administered at 5 PM.

DRUG

Modafinil

See Modafinil Intervention Description above.

Trial Locations (1)

40509

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Catherine Martin, MD

OTHER

NCT00258479 - Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents | Biotech Hunter | Biotech Hunter